The current miRNA analysis has several limitations due to underpowered study design that would consider more adequate inclusion and stratification of other co-morbidities of AD, such as diabetes, cerebrovascular disease, and other factors, such as sex differences and ApoE genotypes. Here, APOE is linked to Alzheimer disease.